338 related articles for article (PubMed ID: 16829954)
1. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.
Sanna MG; Wang SK; Gonzalez-Cabrera PJ; Don A; Marsolais D; Matheu MP; Wei SH; Parker I; Jo E; Cheng WC; Cahalan MD; Wong CH; Rosen H
Nat Chem Biol; 2006 Aug; 2(8):434-41. PubMed ID: 16829954
[TBL] [Abstract][Full Text] [Related]
2. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
[TBL] [Abstract][Full Text] [Related]
3. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Chiba K; Matsuyuki H; Maeda Y; Sugahara K
Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
[TBL] [Abstract][Full Text] [Related]
4. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
Mandala S; Hajdu R; Bergstrom J; Quackenbush E; Xie J; Milligan J; Thornton R; Shei GJ; Card D; Keohane C; Rosenbach M; Hale J; Lynch CL; Rupprecht K; Parsons W; Rosen H
Science; 2002 Apr; 296(5566):346-9. PubMed ID: 11923495
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
[TBL] [Abstract][Full Text] [Related]
6. Lipid-induced phenotypes.
Schultz C
Nat Chem Biol; 2006 Aug; 2(8):396-8. PubMed ID: 16850012
[No Abstract] [Full Text] [Related]
7. Finding a way out: lymphocyte egress from lymphoid organs.
Schwab SR; Cyster JG
Nat Immunol; 2007 Dec; 8(12):1295-301. PubMed ID: 18026082
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.
Wei SH; Rosen H; Matheu MP; Sanna MG; Wang SK; Jo E; Wong CH; Parker I; Cahalan MD
Nat Immunol; 2005 Dec; 6(12):1228-35. PubMed ID: 16273098
[TBL] [Abstract][Full Text] [Related]
9. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
Shiow LR; Rosen DB; Brdicková N; Xu Y; An J; Lanier LL; Cyster JG; Matloubian M
Nature; 2006 Mar; 440(7083):540-4. PubMed ID: 16525420
[TBL] [Abstract][Full Text] [Related]
10. Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog.
Yonesu K; Kawase Y; Inoue T; Takagi N; Tsuchida J; Takuwa Y; Kumakura S; Nara F
Biochem Pharmacol; 2009 Mar; 77(6):1011-20. PubMed ID: 19150609
[TBL] [Abstract][Full Text] [Related]
11. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.
Alfonso C; McHeyzer-Williams MG; Rosen H
Eur J Immunol; 2006 Jan; 36(1):149-59. PubMed ID: 16342326
[TBL] [Abstract][Full Text] [Related]
12. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
Vachal P; Toth LM; Hale JJ; Yan L; Mills SG; Chrebet GL; Koehane CA; Hajdu R; Milligan JA; Rosenbach MJ; Mandala S
Bioorg Med Chem Lett; 2006 Jul; 16(14):3684-7. PubMed ID: 16682185
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
Kohno T; Igarashi Y
Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights.
McVerry BJ; Garcia JG
Cell Signal; 2005 Feb; 17(2):131-9. PubMed ID: 15494205
[TBL] [Abstract][Full Text] [Related]
15. Tipping the gatekeeper: S1P regulation of endothelial barrier function.
Rosen H; Sanna MG; Cahalan SM; Gonzalez-Cabrera PJ
Trends Immunol; 2007 Mar; 28(3):102-7. PubMed ID: 17276731
[TBL] [Abstract][Full Text] [Related]
16. The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice.
Tarrasón G; Aulí M; Mustafa S; Dolgachev V; Domènech MT; Prats N; Domínguez M; López R; Aguilar N; Calbet M; Pont M; Milligan G; Kunkel SL; Godessart N
Int Immunopharmacol; 2011 Nov; 11(11):1773-9. PubMed ID: 21798372
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
[TBL] [Abstract][Full Text] [Related]
18. Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists.
Hale JJ; Doherty G; Toth L; Mills SG; Hajdu R; Keohane CA; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Forrest M; Sun SY; West S; Xie H; Nomura N; Rosen H; Mandala S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3501-5. PubMed ID: 15177461
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish.
Tobia C; Chiodelli P; Nicoli S; Dell'era P; Buraschi S; Mitola S; Foglia E; van Loenen PB; Alewijnse AE; Presta M
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):e104-16. PubMed ID: 22837470
[TBL] [Abstract][Full Text] [Related]
20. Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia.
Sensken SC; Nagarajan M; Bode C; Gräler MH
J Immunol; 2011 Mar; 186(6):3432-40. PubMed ID: 21289303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
